Biomarkers create opportunities, complicate drug dispensing
The healthcare system is coming to grips with the wave of genomic diagnostics that has followed new biological therapy introductions
Global pharma market will hit $1.2 trillion in 2016, with fastest growth in 'pharmerging' markets, says IMS Institute
US growth will be flat through 2013, then jump in 2014 as Obamacare takes effect
Manufacturing a drug therapy--one patient at a time
Dendreon's Provenge prostate-cancer treatment ramps up with unique supply chain complexities
High access to physicians by pharma reps correlates with faster uptake of new medical information
In-depth statistical analysis using ZS Associates and IMS Health prescriber data demonstrates the value of rep-sourced communication
Maintain your integrity: manufacturers and the 340B integrity provision
A Conversation with Cynthia LaConte, Dohmen Company
Dohmen pioneers an integrated, 'conflict free' pharmaceutical services company
Home infusion enhances specialty pharmaceutical distribution
With partial support from manufacturers themselves, home health services are emerging as a critical channel for specialties
Cloud computing enables true multichannel marketing
A cloud-based network of marketing services providers will address the inefficiencies of current multichannel practices
Emerging markets influence changes in global pharma distribution
Visual aids retain an important place in pharma marketing
Agency wins a 'campaign of the year' award from its client, Abbott Labs, for medical display
Data mining/analytics tops the list of IT projects in life sciences manufacturing and supply chain, says IDC Health
Survey responses indicate an overall 7% increase in spending this year, compared to 4% in 2011
Massachusetts backs down its gift-ban and co-pay coupon rules
Restaurant industry joins pharma lobbyists in scaling back meal restrictions; state was the only one to ban co-pay coupons
Cardinal Health targets hospital outpatient pharmacies as a service and revenue opportunity
Rise of accountable care organizations (ACOs) could raise the importance of outpatient pharmacies to life sciences manufacturers
Strategic Marketplace Initiative (SMI) relaunches its website
Healthcare supply-chain group offers free planning and educational resources
Supreme Court upholds most of Affordable Care Act; elements specific to pharmaceuticals are left untouched
Billy Tauzin’s PhRMA legacy and the 'broccoli horrible' discussion
'Bioscience' industry continues to grow through the past recession, says Battelle
Battelle's biennial survey adds 'bioscience-related distribution' to industry sectors it tracks
More companies enter the cold-chain distribution arena
Continuing growth attracts more players; meanwhile, Sensitech acquires FreightWatch International to beef up real-time monitoring
Evaluate Pharma predicts top companies, products in 2018
Novartis could overtake Pfizer as No. 1, while Merck's Januvia/Janumet franchise will approach $10 billion in annual sales
More cloak-and-dagger details about the 2010 Eli Lilly Enfield drug heist come out
Attempts were made to relabel stolen product with counterfeit labels, says NJ Star-Ledger
Walgreens-Alliance Boots merger could redefine retail pharmacy
Combination will create the world's largest single buyer of pharmaceuticals
Federal pedigree/track-and-trace rules appear to be dead, for now
FDA Safety and Innovation Act is ready for final passage
Carbon dioxide (CO2) emissions from cold-chain shipments can affect aircraft environments
FedEx takes precautionary steps to manage CO2 outgassing in their newest B-777 aircraft
PDUFA bumps its way toward passage
Meanwhile, all eyes were on the Supreme Court’s expected ruling on Obamacare
Pharma distribution technologies start heading for the 'cloud'
Systech builds on its packaging execution/serialization capabilities with an acquisition
A new source of pharma marketing analytics: Symphony Health Solutions
Private-equity firm builds a competitor in pharma sales analytics
Merck Serono and Dr. Reddy's will collaborate on biosimilars
Monoclonal antibodies (MAbs) for oncology will be initial target
A conversation with Jeffrey Berkowitz, Walgreens
The leading chain pharmacy steps up its role as healthcare provider and partner to pharma
